RSS

02.03.12 -- Boehringer Ingelheim Prolongates Drug Discovery Collaboration With Priaxon

February 3, 2012

Featured Article

Benzoxaboroles: A New Potential Drug for African Sleeping Sickness
By SCYNEXIS Inc.
Human African trypanosomiasis, caused by the kinetoplastid parasite Trypanosoma brucei, affects thousands of people across sub-Saharan Africa, and is fatal if left untreated. Treatment options for this disease, particularly stage 2 disease, which occurs after parasites have infected brain tissue, are limited due to inadequate efficacy, toxicity, and the complexity of treatment regimens.

Industry News
	Boehringer Ingelheim Prolongates Drug Discovery Collaboration With Priaxon
	Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib
	Curis Announces FDA Approval Of Treatment For Advanced Basal Cell Carcinoma
	Grace Announces Patent Notice Of Allowance For Flash Chromatography Technology
	Kaluza 1.2 Cytometry Software From Beckman Coulter Provides Speed, Enhanced Ease Of Use
	NovAliX Enters Into Multi-Target Integrated Drug Discovery Collaboration With Teijin Pharma
	Update On The Spinal Muscular Atrophy Drug Development Pipeline From Families Of SMA
	DNDi And Abbott Expand Partnership To Boost Innovation For Neglected Tropical Diseases
	Marken Announces New Corporate Team To Develop Industry Changing Technologies
	Eppendorf Acquires DASGIP Group
View more headlines

Featured Downloads
Brochure: Pharmaceutical Analysis Contract Services
BASi scientists can provide support for all phases of your drug development, from early stage API method development to post-commercialization product testing.

Datasheet: Low Solubility Compounds
A variety of approaches are often needed to improve the bioavailability of low solubility BCS class II and IV compounds. For tackling the bioavailability challenges of BCS class II and IV compounds, proven formulation development and analytical and manufacturing capabilities are available at Patheon's facilities.
Browse the download library

Industry Events
BioNetwork East
March 5 to 7, 2012 \| Miami, FL Enter code BEVERT to receive 25% off the full price

2012 AAPS National Biotechnology Conference
May 19 to 24, 2012 \| San Diego, CA

Featured Products And Services
Discovery Services MPI Research provides a broad range of research models integrated with state-of-the-art test methods and analytics to help sponsors identify and develop life-changing therapies. • Download Brochure • Request Information MPI Research

Medical Devices And Equipment Marken has trained professionals with global expertise to protect and manage the logistics of medical devices, diagnostic equipment, and medical components including sensitive microchips and surgical equipment with expertise in ECG/ABM devices, stents, pace makers, and investigator site specimen separation devices. • Download Product Sheet • Request Information Marken

Free Drug Discovery Online Newsletter